DRD4 Drives Chemoresistance via PI3K/Akt/β-Catenin in Liver
2026-08-03
This study elucidates how dopamine receptor D4 (DRD4) enhances chemoresistance and cancer stem cell traits in hepatocellular carcinoma by activating the PI3K/Akt/β-catenin pathway. The findings highlight DRD4 as a promising therapeutic target for overcoming drug resistance and tumor recurrence in liver cancer.
Capillary Electrochromatography for β2-AR Drug Binding Analy
2026-08-03
This study introduces a novel open-tubular capillary electrochromatography method to determine binding constants between the β2-adrenergic receptor and seven drugs, including norepinephrine bitartrate. The approach reduces protein consumption and enhances throughput, offering robust affinity profiling for cardiovascular research and drug screening.
N4-Acetylcytidine: Structural Insights and Assay Optimizatio
2026-08-02
Explore how N4-Acetylcytidine advances RNA epigenetics research, with novel structural insights for assay optimization. This article uniquely bridges high-purity product features with the latest mechanistic discoveries in nucleotide processing.
Aprotinin (BPTI): Beyond Hemostasis—Assay Integrity and RBC
2026-08-01
Discover how aprotinin (bovine pancreatic trypsin inhibitor) advances both blood management and cell membrane research. This in-depth article reveals novel assay applications and integrates new insights from red blood cell cytoskeleton mechanics.
CGRP–RAMP1 Axis Restricts CD4+ T Cell Activation in Allergy
2026-07-31
Li et al. (2025) uncover a neuroimmune mechanism whereby the CGRP–RAMP1 pathway directly suppresses CD4+ T cell activation and differentiation, limiting allergic sensitization and asthma progression. Their integrative approach highlights new avenues for modulating adaptive immunity and allergic disease.
PARP1/FAK/COL5A1 Axis Drives EMT in Cholesterol-Resistant Ov
2026-07-31
This study reveals that persistent high cholesterol exposure in ovarian cancer cells activates the PARP1/FAK/COL5A1 signaling axis, promoting epithelial-mesenchymal transition (EMT) and tumorigenesis. These findings elucidate a mechanistic link between cholesterol metabolism and cancer progression, offering new intervention points for cancer biology research.
Golgi-Tracker Green: Live-Cell Golgi Imaging for Lipid Pathw
2026-07-30
Golgi-Tracker Green, powered by BODIPY FL-labeled C5-ceramide, delivers unmatched specificity and photostability for live-cell Golgi apparatus labeling. This probe empowers researchers to dissect lipid transport pathways and sphingolipid metabolism in real time, outperforming traditional fluorescent tools and advancing translational research in cellular and cancer biology.
FITC Goat Anti-Rabbit IgG (H+L) Antibody: Mechanistic Insigh
2026-07-30
Explore how the FITC Goat Anti-Rabbit IgG (H+L) Antibody enhances immunofluorescence accuracy and sensitivity. This article uniquely bridges antibody mechanism, advanced protocol optimization, and translational relevance for researchers seeking robust, reproducible detection solutions.
Carbapenemase Gene Dynamics in CREC: Resistance and Epidemio
2026-07-29
This study provides a detailed molecular and epidemiological analysis of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from Guangdong hospitals during the COVID-19 pandemic. Its findings clarify gene distribution, transmission dynamics, and multidrug resistance profiles, offering actionable insights for research on antibiotic resistance mechanisms.
Mild ER Stress Enhances Cadmium Resistance in C. elegans
2026-07-29
This study reveals that mild activation of the endoplasmic reticulum unfolded protein response (UPRER) confers significant cadmium resistance in Caenorhabditis elegans, dependent on the IRE-1/XBP-1 signaling branch. The findings clarify how precise modulation of ER stress pathways can promote protein homeostasis and cellular resilience to environmental toxins.
Intravesical p21 mRNA-LNP Therapy: A Localized Approach for
2026-07-28
This study pioneers the use of intravesical delivery of p21 mRNA–loaded lipid nanoparticles (LNPs) as a tumor suppressor replacement therapy for non–muscle-invasive bladder cancer. The research demonstrates robust restoration of p21 expression and tumor suppression with favorable safety, highlighting a clinically viable gene therapy approach.
OSMI-1: Applied O-GlcNAc Transferase Inhibitor for Protein W
2026-07-28
OSMI-1 empowers researchers with precise, cell-permeable inhibition of O-GlcNAc transferase, enabling advanced mechanistic studies in protein O-GlcNAcylation, ferroptosis, and placental biology. Its robust performance and validated protocols make it a benchmark tool for dissecting O-GlcNAc-dependent processes in both in vitro and in vivo systems.
Pregnenolone Carbonitrile: Enabling CYP3A and Antifibrotic A
2026-07-27
Pregnenolone Carbonitrile (PCN) unlocks robust PXR-driven workflows for cytochrome P450 induction and antifibrotic studies, now with new CNS water homeostasis insights. Leveraging APExBIO’s C3884 formulation ensures high-purity, reproducible results across hepatic and translational models.
Standardizing Norepinephrine Formulation Reporting in Critic
2026-07-27
A joint position paper by SCCM and ESICM addresses global inconsistencies in norepinephrine formulation labeling and reporting, emphasizing the consequences for clinical dosing, trial enrollment, and data harmonization. The task force advocates for uniform norepinephrine-base reporting to improve patient safety and research reproducibility, providing practical guidance for researchers and clinicians.
cgSHAPE-seq Maps RNA-Degrading Chimera Binding in SARS-CoV-2
2026-07-26
This study introduces chemical-guided SHAPE sequencing (cgSHAPE-seq), an innovative method to map ligand-RNA interactions at single-nucleotide resolution. Using this approach, researchers identified precise binding sites of coumarin-based RNA-degrading chimeras on the SARS-CoV-2 5' UTR, with implications for targeted antiviral strategies.
464 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page